## Dynamic antibody response in SARS-CoV-2 infected patients and COVID-19 vaccine recipients alongside vaccine effectiveness in comorbid and multimorbid groups 

[![DOI:10.1016/j.heliyon.2023.e16349](http://img.shields.io/badge/DOI-10.1016/j.heliyon.2023.e16349-informational.svg)](https://doi.org/10.1016/j.heliyon.2023.e16349) 

**Description of the Repository** <br/> 
This repository contains the supplementary materials to support the peer-reviewed original research article published under the following title, *“Dynamic antibody response in SARS-CoV-2 infected patients and COVID-19 vaccine recipients alongside vaccine effectiveness in comorbid and multimorbid groups.”* The supplementary materials are anonymized and do not contain any direct or indirect identifiers in order to ensure patient confidentiality. <br/> 

The article is published in [*Heliyon, Cell Press*](https://www.cell.com/heliyon/home) and can be accessed through the following DOI identifier : [doi.org/10.1016/j.heliyon.2023.e16349](https://doi.org/10.1016/j.heliyon.2023.e16349)  

**Patient and Public Involvement Statement** <br/>
* All the participants were enlisted for the study after obtaining informed written consent. Patients were enrolled at the time of sample collection after examining their medical histories. 

**Research Ethics Approval** <br/> 
* The protocols were approved by the institutional ethics committee at Central Police Hospital, Dhaka, and complied with the *International Conference on Harmonisation Guideline for Good Clinical Practice* and the *Declaration of Helsinki*. All patients provided written informed consent according to local guidelines. 

**Funding statement** <br/> 
* This research was funded by the Central Police Hospital, Dhaka, Bangladesh. 

**Suggested Citation (Harvard)** <br/> 
* Das, D. et al. (2023) ‘Dynamic antibody response in SARS-CoV-2 infected patients and COVID-19 vaccine recipients alongside vaccine effectiveness in comorbid and multimorbid groups’, Heliyon, 0(0), p. e16349. Available at: https://doi.org/10.1016/J.HELIYON.2023.E16349.  

_**Depro Das**_ <br/> 
*Systems Cell-Signalling Laboratory <br/> 
Department of Biochemistry and Molecular Biology <br/> 
University of Dhaka, Dhaka 1000, Bangladesh*   
